About Us
We are a biotechnology research and investment holding company focused on the exploration, discovery, development, cultivation, and application of the science behind regenerative medication, immunotherapy, and stem cell treatments.
A biotechnology research company in partnership with US FDA Compliant partners that aims to provide cell-based medical treatments as alternatives for patients suffering from cancer, aging, antiviral, and diabetic disease-based symptoms.
Good health is the foundation of vibrant lives, thriving communities, and forward progress. As a responsible healthcare company, we are committed to using our knowledge and research for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body, and environment within reach of everyone, everywhere.
Our Belief
The science to overcome the characteristics of aging to ultimately delay the inevitable, rather than the individual treatment for specific diseases. This drives our vision and pursuit for scientifically proven PREVENTIVE medical alternatives for our customers.
Our Vision
To be the leader of PREVENTIVE healthcare services in the science and application of
Regenerative Medicine, and Immunotherapy.
Our Mission
To educate and provide patients with alternative medications to fight diseases and alleviate medical conditions through the introduction and use of cell-based therapies.
Our Value Proposition
Provider of Preventive, Regenerative & Restorative therapies, and services -
A facilitator of longer living & healthier lifestyles.
Patrick Tan
Founder & Executive Chairman
A visionary industrialist and entrepreneur inspired to take state-of-the-art inventions from the lab to the bedside. His ambition to bring together the next generation of medical treatments and to make it available for the masses.
Patrick Tan
Michael Chieng
Jordan Chua
Knowledge & Expertise
Awareness and education on stem cell-based treatments from renowned experts of the field
Alternative Medical Solutions
Provider of alternative treatments for critical ailments e.g., stem cell vs chemotherapy
Costs
Russell Chia Lek Ming
Dato' Tony Looi Chee Hong
Dato Sri (Dr) Chong Chin Fung
Tan Seri Datuk Seri Tan Kean Soon
Business Advisory Team
Founder
Board of Directors
Ryan Liong
Group Finance Manager
Jordan Chua
Executive Director YICT
Management & Operations Team
Dr Gopinathan
Pain Management
Dato' Dr Krishnamoorthy
Healthcare Consultant
Health Management, Regenerative & Immunotherapy clinical services
Yakin ICT Management Sdn Bhd
Systems enablement, AI applications development & data analysis
Yakin Splendour Sdn Bhd
Intellectual Property Rights & Licensing, Product Registration & Distribution
Yakin Splendour Southeast Asia Sdn Bhd
Driver for regional market expansion plans through strategic collaborations